MedPath

BIOBAY� REZWEL CAPSULE

Registration Number: MAL24086064TC

Approved
Approval ID

0a04b9d48b21270b

Registration Number

MAL24086064TC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types9 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (9)

10 CapsulesAvailable
Package Size: 10 Capsules
Status: NPRA Approved
30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved
150 CapsulesAvailable
Package Size: 150 Capsules
Status: NPRA Approved
180 CapsulesAvailable
Package Size: 180 Capsules
Status: NPRA Approved
200 CapsulesAvailable
Package Size: 200 Capsules
Status: NPRA Approved
20 CapsulesAvailable
Package Size: 20 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (5)

Apocynum venetumActive
Monograph: apocynum venetum
Passiflora incarnataActive
Lycium barbarumActive
Monograph: lycium barbarum
Humulus lupulusActive
Monograph: humulus lupulus
Valeriana officinalisActive
Monograph: valeriana officinalis

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BIOBAY� REZWEL CAPSULE - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform